Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487628 | Journal of Pharmaceutical Sciences | 2007 | 10 Pages |
Abstract
CpG ODN are tollâlike receptor 9 (TLR9) agonists that can enhance antigen presentation by antigen presenting cells (APCs) such as dendritic cells (DCs). The most potent antigenâspecific responses are seen when CpG ODN and the antigen are coâlocalized in the same APC. CpG ODN-antigen fusion molecules and biodegradable microparticles entrapping CpG ODN and antigen can ensure both components are delivered to the same APC. In this study, we compared the efficacy of the CpG-ODN fusion molecules against biodegradable microparticles entrapping antigen and CpG ODN. Microparticles were prepared using a double emulsion solvent evaporation methodology. CpG ODN-OVA fusion molecules were prepared by mixing maleimideâactivated protein with thiolated CpG ODN. Both CpG ODN-OVA fusion molecules and microparticles coâentrapping CpG ODN and OVA generated stronger IgG2a and interferonâgamma (IFNâγ) responses than delivery of soluble CpG ODN and OVA. The microparticles generated stronger IgG2a and IFNâγ immune responses than did CpG ODNâantigen fusion molecules. © 2007 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 96: 3283-3292, 2007
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
XueâQing Zhang, Christopher E. Dahle, George J. Weiner, Aliasger K. Salem,